Randolph Company’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-4,123
| Closed | -$346K | – | 45 |
|
|
2025
Q3 | $346K | Hold |
4,123
| – | – | 0.03% | 36 |
|
|
2025
Q2 | $326K | Sell |
4,123
-201,104
| -98% | -$16M | 0.03% | 39 |
|
|
2025
Q1 | $18.4M | Sell |
205,227
-843
| -0.4% | -$78.7K | 2.16% | 24 |
|
|
2024
Q4 | $20.5M | Buy |
206,070
+1,049
| +0.5% | +$108K | 2.29% | 21 |
|
|
2024
Q3 | $23.3M | Sell |
205,021
-132
| -0.1% | -$15.7K | 2.71% | 20 |
|
|
2024
Q2 | $25.4M | Buy |
205,153
+47
| +0% | +$6.05K | 3.11% | 14 |
|
|
2024
Q1 | $27.1M | Buy |
205,106
+202,278
| +7,153% | +$24.9M | 3.32% | 11 |
|
|
2023
Q4 | $308K | Buy |
2,828
+102
| +4% | +$10.6K | 0.04% | 41 |
|
|
2023
Q3 | $281K | Hold |
2,726
| – | – | 0.05% | 40 |
|
|
2023
Q2 | $315K | Hold |
2,726
| – | – | 0.04% | 44 |
|
|
2023
Q1 | $290K | Hold |
2,726
| – | – | 0.04% | 47 |
|
|
2022
Q4 | $302K | Hold |
2,726
| – | – | 0.05% | 43 |
|
|
2022
Q3 | $235K | Hold |
2,726
| – | – | 0.04% | 46 |
|
|
2022
Q2 | $249K | Hold |
2,726
| – | – | 0.04% | 46 |
|
|
2022
Q1 | $224K | Hold |
2,726
| – | – | 0.03% | 47 |
|
|
2021
Q4 | $209K | Hold |
2,726
| – | – | 0.03% | 48 |
|
|
2021
Q3 | $205K | Hold |
2,726
| – | – | 0.03% | 46 |
|
|
2021
Q2 | $212K | Sell |
2,726
-241,030
| -99% | -$17.9M | 0.03% | 46 |
|
|
2021
Q1 | $17.9M | Buy |
243,756
+75
| +0% | +$5.53K | 2.45% | 22 |
|
|
2020
Q4 | $19M | Buy |
243,681
+532
| +0.2% | +$40.7K | 2.82% | 18 |
|
|
2020
Q3 | $19.2M | Sell |
243,149
-47
| -0% | -$3.68K | 3.31% | 14 |
|
|
2020
Q2 | $17.9M | Hold |
243,196
| – | – | 3.21% | 15 |
|
|
2020
Q1 | $17.9M | Buy |
+243,196
| New | +$19.1M | 3.54% | 11 |
|
|
2017
Q4 | – | Sell |
-14,767
| Closed | -$902K | – | 42 |
|
|
2017
Q3 | $902K | Hold |
14,767
| – | – | 0.17% | 35 |
|
|
2017
Q2 | $903K | Hold |
14,767
| – | – | 0.17% | 35 |
|
|
2017
Q1 | $895K | Sell |
14,767
-1,452
| -9% | -$88.1K | 0.17% | 36 |
|
|
2016
Q4 | $911K | Hold |
16,219
| – | – | 0.19% | 37 |
|
|
2016
Q3 | $966K | Hold |
16,219
| – | – | 0.24% | 29 |
|
|
2016
Q2 | $892K | Hold |
16,219
| – | – | 0.23% | 27 |
|
|
2016
Q1 | $819K | Hold |
16,219
| – | – | 0.18% | 32 |
|
|
2015
Q4 | $817K | Hold |
16,219
| – | – | 0.21% | 29 |
|
|
2015
Q3 | $764K | Buy |
+16,219
| New | +$862K | 0.18% | 36 |
|
Other funds holding MRK
Randolph Company's MRK Position: Q4 2025 in Review
Randolph Company sold out of Merck (MRK) in Q4 2025, closing a stake of 4,123 shares — an estimated $346K sold.
Randolph Company first reported a position in MRK in Q3 2015 and held it in 32 quarters. The position peaked at $27.1M in Q1 2024. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.
- Randolph Company reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
- Randolph Company sold 4,123 Merck shares in Q4 2025, an estimated $346K.
- Randolph Company first reported a position in Merck in Q3 2015 and held it in 32 quarters.
- Randolph Company's Merck position peaked at $27.1M in Q1 2024.
- 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.
Based on Randolph Company's 13F filing for Q4 2025, filed 11 Feb 2026.